Thursday, January 10, 2019
MZ Digital Marketing Agency
Doctors, drug firms and the nation’s top drug regulator say the companies that make costly name-brand biologic drugs, which are grown from living cells, are sowing doubt about the wisdom of switching to generic versions — even though the FDA has certified they are safe and effective.
from Washington Post: Breaking News, World, US, DC News & Analysis https://wapo.st/2D2a1rd
Thursday, January 10, 2019
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment